Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.63 is 922% below its 5-year average of -0.06, near the low end of its 5-year range (-0.63–0.58).
209.57% below its 12-month average of 0.57.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.37.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 19 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-09-15T19:05:37.316Z. Historical observations retain their original dates. Historical series through 2026-05-11.
EARNINGS PER SHARE (EPS)
-0.63
EARNINGS PER SHARE (EPS) AVG TTM
0.57
EARNINGS PER SHARE (EPS) AVG 3Y
0.18
EARNINGS PER SHARE (EPS) AVG 5Y
-0.06
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-209.57%
CURRENT VS 3Y AVG
-450.00%
CURRENT VS 5Y AVG
-921.62%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Hims & Hers Health, Inc.
Market Cap
$6.30B
Earnings Per Share (EPS)
-0.63
TTM Avg
0.57
3Y Avg
0.18
5Y Avg
-0.06
Market Cap
$6.65B
Earnings Per Share (EPS)
19.92
TTM Avg
19.26
3Y Avg
18.34
5Y Avg
18.42
Market Cap
$5.88B
Earnings Per Share (EPS)
-3.31
TTM Avg
-2.88
3Y Avg
-2.49
5Y Avg
-2.72
Market Cap
$5.15B
Earnings Per Share (EPS)
2.42
TTM Avg
2.12
3Y Avg
1.80
5Y Avg
1.31
Market Cap
$4.86B
Earnings Per Share (EPS)
0.85
TTM Avg
1.12
3Y Avg
0.90
5Y Avg
0.76
Market Cap
$8.50B
Earnings Per Share (EPS)
1.40
TTM Avg
-0.79
3Y Avg
-1.41
5Y Avg
-1.76
Market Cap
$3.08B
Earnings Per Share (EPS)
3.86
TTM Avg
3.33
3Y Avg
1.17
5Y Avg
0.32
Market Cap
$9.96B
Earnings Per Share (EPS)
3.43
TTM Avg
3.18
3Y Avg
3.37
5Y Avg
3.47
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Hims & Hers Health, Inc. (HIMS) | $6.30B | -0.63 | 0.57 | 0.18 | -0.06 |
| Chemed Corporation (CHE)vs › | $6.65B | 19.92 | 19.26 | 18.34 | 18.42 |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.88B | -3.31 | -2.88 | -2.49 | -2.72 |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.15B | 2.42 | 2.12 | 1.80 | 1.31 |
| Doximity, Inc. (DOCS)vs › | $4.86B | 0.85 | 1.12 | 0.90 | 0.76 |
| Oscar Health, Inc. (OSCR)vs › | $8.50B | 1.40 | -0.79 | -1.41 | -1.76 |
| TransMedics Group, Inc. (TMDX)vs › | $3.08B | 3.86 | 3.33 | 1.17 | 0.32 |
| Insulet Corp. (PODD)vs › | $9.66B | 5.35 | 4.74 | 3.13 | 2.14 |
| Henry Schein, Inc. (HSIC)vs › | $9.96B | 3.43 | 3.18 | 3.37 | 3.47 |
| Globus Medical, Inc. (GMED)vs › | $10.10B | 3.89 | 2.37 | 1.93 | 1.71 |
Trailing EPS (TTM)
$-0.63
Forward EPS (Est.)
$-0.59
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 0.57 |
| 2024-12-31 | 0.58 |
| 2023-12-31 | -0.11 |
| 2022-12-31 | -0.32 |
| 2021-12-31 | -0.58 |
| 2020-12-31 | -0.51 |
| 2019-12-31 | -2.07 |
